the aid library

LIST OPTIONS

Filter

7847

Sort by:

Direction:

Download (102)

View PDF (155)

HIV financing status in selected countries of the Western Pacific Region (2009-2015)

World Health Organization (Western Pacific Region) (2016) C_WHO

Download (411)

View PDF (722)

Community Health Worker Incentives in Malawi: Lessons Learned

USAID (2015) C1

Download (835)

View PDF (1541)

Early Recovery and Resilience Support Framework: Guinea, Liberia and Sierra Leone (May 2015 - October 2016)

UN Development Programme (2015)

Download (915)

View PDF (2387)

Assessment of HIV in Internally Displaced Situations

Inter-Agency Task Team to Adress HIV in Humanitarian Emergencies UNHCR (2014) C1

Download (498)

View PDF (1675)

Crisis Emergency Risk Communication. Manual
recommended

Centers for Disease Control and Prevention; US Dept. of Health and Human Services (2014) CC

Download (204)

View PDF (461)

Global data on visual impairments 2010

World Health Organization (WHO) (2012) C_WHO

Download (1319)

View PDF (1196)

NO-SCALPEL VASECTOMY

EngenderHealth (2003)

An Illustrated Guide for Surgeons Third Edition

Download (1065)

View PDF (1664)

Developing Pharmacy Practice - A focus on patient care

Wiedenmayer, K. et al. World Health Organization (WHO), International Pharmaceutical Federation (FIP) (2006) C_WHO

English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,... more

Download (128)

View PDF (125)

National Cancer Handling Guidelines

Ministry of Health, Kenya (2020) C1

Download (113)

View PDF (155)

Minimum Standards for the Protection of Refugees and Migrants in Refugee Accommodation Centres

BMFSFJ, Unicef (2017) C_UNICEF

Guidelines for the development and implementation of institution-specific protection concepts

Download (67)

View PDF (158)

UNAIDS Terminology Guidelines

UNAIDS (2024) CC

Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind... more

Download (1907)

View PDF (1344)

Selection and Use of Essential Medicines 2021
recommended

World Health Organization WHO (2021) C_WHO

The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo... more

Download (298)

View PDF (367)

Progress on drinking water, sanitation and hygiene in schools: 2000-2021 data update

World Health Organization WHO; UNICEF; et al. (2022) C_WHO

Special Focus on COVID-19 The report provides updated estimates for drinking water, sanitation and hygiene in schools including progress from 2015 to 2019. It highlights the rapid improvement needed to ensure students have access to handwashing facilities with soap and water during the COVID-19 pan... more

Download (165)

View PDF (400)

Progress on household drinking water, sanitation and hygiene 2000-2020: Five years into the SDGs

World Health Organization WHO; UNICEF (2021) C_WHO

The Joint Monitoring Programme (JMP) report – Progress on household drinking water, sanitation and hygiene 2000 - 2020 – presents estimates on household access to safely managed drinking water, sanitation and hygiene services over the past five years, and assesses progress toward achieving the s... more

Download (399)

View PDF (854)

Integrating palliative care and symptom relief into responses to humanitarian emergencies and crises: a WHO guide

World Health Organization WHO (2018) C_WHO

Humanitarian emergencies and crises (Humanitarian emergencies and crises) are large-scale events that may result in the breakdown of health care systems and society, forced displacement, death, and physical, psychological, social and spiritual suffering on a massive scale. Current responses to Human... more

Download (211)

View PDF (226)

Anxiety disorders
recommended

National Institute for Health and Care Excellence (NICE) (2014) C2

Download (247)

View PDF (281)

صحة الدورة الشهرية والنظافة للفتيات والنساء ذوات الإعاقة

Unicef (2021) C_UNICEF

Menstrual Health & Hygiene for Girls and Women with Disabilities in Arabic

Download (276)

View PDF (373)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more